Literature DB >> 8195231

c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb.

C Kanei-Ishii1, T Yasukawa, R I Morimoto, S Ishii.   

Abstract

The c-myb proto-oncogene product (c-Myb) can transactivate the human hsp70 promoter in a transient cotransfection assay. The present studies have demonstrated that the heat shock element (HSE) in the hsp70 promoter mediates trans-activation by c-Myb. Mutagenesis of the DNA sequence in HSE indicated that the NGAAN motif is necessary for not only the heat shock response but also the c-Myb-induced trans-activation. The HSE in the hsp70 promoter does not contain a c-Myb-binding site, implying that the sequence-specific DNA binding of c-Myb is not required for the HSE-dependent trans-activation by c-Myb. We had demonstrated that a disruption of the leucine zipper motif in the central portion of the c-Myb molecule increased the degree of c-Myb-induced trans-activation of the promoter containing c-Myb-binding sites, suggesting that a putative inhibitor binds to c-Myb through this leucine zipper (Kanie-Ishii, C., MacMillan, E. M., Nomura, T., Sarai, A., Ramsay, R. G., Aimoto, S., Ishii, S., and Gonda, T. J. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 3088-3092). However, disruption of the leucine zipper in c-Myb abolished the HSE-dependent trans-activation by c-Myb, whereas deletion of the transcriptional activation domain containing acidic amino acids in c-Myb did not abolish the HSE-dependent trans-activation by c-Myb. These results suggest that c-HSEs by interacting with unidentified trans-acting factor(s) but not by a direct binding to the promoter through its DNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Heat shock factor function and regulation in response to cellular stress, growth, and differentiation signals.

Authors:  K A Morano; D J Thiele
Journal:  Gene Expr       Date:  1999

2.  Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Steven McClellan; William E Grizzle; Eddie Reed; Ajay P Singh
Journal:  Carcinogenesis       Date:  2012-03-19       Impact factor: 4.944

3.  Myb-related fission yeast cdc5p is a component of a 40S snRNP-containing complex and is essential for pre-mRNA splicing.

Authors:  W H McDonald; R Ohi; N Smelkova; D Frendewey; K L Gould
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

4.  c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer.

Authors:  C Hernandez-Munain; M S Krangel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

5.  Myb-related Schizosaccharomyces pombe cdc5p is structurally and functionally conserved in eukaryotes.

Authors:  R Ohi; A Feoktistova; S McCann; V Valentine; A T Look; J S Lipsick; K L Gould
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  A central role for a single c-Myb binding site in a thymic locus control region.

Authors:  K C Ess; T L Whitaker; G J Cost; D P Witte; J J Hutton; B J Aronow
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

7.  Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein.

Authors:  Ryan S Cross; Jordane Malaterre; Alexander J Davenport; Sandra Carpinteri; Robin L Anderson; Phillip K Darcy; Robert G Ramsay
Journal:  Clin Transl Immunology       Date:  2015-01-09

8.  Transcriptome-wide association study identifies putative elicitors/suppressor of Puccinia graminis f. sp. tritici that modulate barley rpg4-mediated stem rust resistance.

Authors:  Roshan Sharma Poudel; Jonathan Richards; Subidhya Shrestha; Shyam Solanki; Robert Brueggeman
Journal:  BMC Genomics       Date:  2019-12-16       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.